FDA Seeks Input on Interchangeability of Biosimilar Insulins FDA Seeks Input on Interchangeability of Biosimilar Insulins

Some argue that interchangeability testing requirements should be less stringent for insulin products than for other biosimilars.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news